Abcam PLC (LSE:ABC) - Share price - Overview

Stock Report

Abcam PLC ABC

Last Price
GBX1,030.00

Day Change
4.00|0.39%

As of 22/09/2017
17:05:36 BST | GBX
Minimum 15 Minutes Delay.

Last Close1,026.00p
Day Range1,021.00 - 1,036.00
Mkt Cap2.10Bil
52-Wk Range759.50 - 1,113.00
Yield %0.91
ISINGB00B6774699
Volume268,869
P/E49.65
P/S12.07
P/CF43.79

Share Price

Total Returns 22/09/2017

 Chg (%)  
More ...
Abcam PLC-3.29 
FTSE 100 TR GBP-0.82
 
Financials
201520162017
More ...
Income Statement
Turnover144.03171.67-
Operating Profit45.7346.32-
Net Profit37.3837.43-
Reported EPS18.5718.53-
Balance Sheet
Current Assets99.84118.86-
Non Current Assets149.42209.91-
Total Assets249.95329.56-
Current Liabilities21.0633.29-
Total Liabilities35.8468.37-
Total Equity214.10261.19-
Cash Flow
Operating Cash Flow48.8956.80-
Net Change in Cash1.5510.40-
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
--------
--------

Regulatory News

Director Dealings
TradedActionNotifierPriceAmountValue
More ...
14/09/2017PurchaseLady Louise Patten of Wincanton1,078.731,63617,648.00
14/09/2017PurchaseMr Murray Hennessy1,078.736,55470,700.00
14/09/2017PurchaseDr. Jonathan Milner1,078.732,06822,308.00
14/09/2017PurchaseSue Harris1,078.731,62517,529.00

Company Profile

Abcam PLC is a biotechnology company engaged in developing antibodies for life science research and clinical communities. It works on regulatory molecules and proteins in biological pathways to treat diseases like cancer and immune deficiency disorders.

Sector

Biotechnology

Market Position

190 of 1837 Companies

Index

FTSE AIM UK 50 ,FTSE AIM 100 ,FTSE AIM All Share

Outlook

(11/09/2017) ch - "We remain confident that we have the right strategy and the right people to achieve our long-term goals and build significant value for all our stakeholders"

Next Event 26/09/2017

Next annual report due
Ratios
CompSecMkt
More ...
PER (E)0.0012.9416.05
Div Yld (E)0.004.054.18
PEG (E)0.000.730.90
ROCE0.00191.3613.73
Op Mrgn0.00-4.32-15.22
EPS Grwth0.0021.8819.70
Dividends
PreviousLatest
More ...
Record Date11/11/1617/03/17
Ex-Div10/11/1616/03/17
Paid02/12/1613/04/17
Amnt6.562.83

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr Murray Hennessy
Chief Executive OfficerMr. Alan Hirzel
Chief Financial OfficerGavin Wood
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.